Immune Monitoring of Hepatitis C Under DAA Therapy

Prospective Monitoring of Immune Parameters in Patients With Hepatitis C Under Treatment With Direct Acting Antivirals

Direct acting antivirals offer a new opportunity to monitor the immune response in Hepatitis C infection. In this study cytokine markers will be measured during therapy up to time point SVR 12 an correlated to clinical Parameters and regular laboratory findings.

Inclusion Criteria:

• written consent, age, HCV-RNA positive, DAA therapy

Exclusion Criteria:

-